Table 1. Demographic Data of Study Participantsa.
| Value | Placebo Group, n = 24 | Low-Dose Cuminum cyminum L. Plus Lime Group, n = 24 | High-Dose Cuminum cyminum L. Plus Lime Group, n = 24 | P Valueb |
|---|---|---|---|---|
| Gender | 1.00c | |||
| Male | 2 (8.3) | 2 (8.3) | 2 (8.3) | |
| Female | 22 (91.7) | 22 (91.7) | 22 (91.7) | |
| Age, y | 40.1±11.3 | 33.2 ± 11.8 | 34.5 ± 10.2 | 0.08 |
| Height, cm | 160.8 ± 7.0 | 164.2 ± 5.6 | 162.9 ± 6.1 | 0.18 |
| Weight at study baseline, kg | 83.4 ± 15.4 | 89.5 ± 16.1 | 82.3 ± 13.6 | 0.21 |
| Weight at end-of-trial, kg | 83.6 ± 15.8 | 88.3 ± 16.6 | 80.2 ± 13.5 | 0.20 |
| Weight change, kg | 0.2 ± 1.3 | -1.2 ± 1.5d | -2.1 ± 1.7d | < 0.001 |
| BMI at study baseline, kg/m 2 | 32.4 ± 6.3 | 33.2 ± 5.6 | 31.1 ± 5.0 | 0.41 |
| BMI at end-of-trial, kg/m 2 | 32.5 ± 6.5 | 32.7 ± 5.8 | 30.3 ± 5.0 | 0.27 |
| BMI change, kg/m 2 | 0.1 ± 0.5 | -0.5 ± 0.5d | -0.8 ± 0.6d | < 0.001 |
| MET-h/d | 28.5 ± 2.3 | 28.7 ± 2.1 | 28.9 ± 2.0 | 0.85 |
| SBP, mmHg | 118.7 ± 4.5 | 119.1 ± 4.2 | 119.2 ± 4.1 | 0.90 |
| DBP, mmHg | 79.5 ± 3.1 | 79.1 ± 2.8 | 79.4 ± 2.9 | 0.90 |
aValues are expressed as means ± SD or No. (%).
bObtained from ANOVA test.
cObtained from Pearson Chi-square test.
dSignificant difference with the placebo group.
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; METs, metabolic equivalents; SBP, systolic blood pressure.